Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

9.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic infectome-phenome profiling reveals cryptococcal infection-associated proteins driving immune system remodeling and immunization potential.

iScience·2026
Same author

Editorial: Advances in systems biology and bioinformatics for microbiology research.

Canadian journal of microbiology·2026
Same author

Microfluidics-enabled proteomic profiling reveal iron-driven immune evasion by an antimicrobial-resistant pathogen.

Cell reports methods·2026
Same author

Lon protease-mediated secretome profiling in <i>Klebsiella pneumoniae</i>.

Microbiology resource announcements·2026
Same author

How similar are humans and chimpanzees in expressed proteins as estimated by mass spectrometry-based serum proteomics?

Gene·2026
Same author

The infection-exclusive proteome of murine extracellular vesicles defines <i>Klebsiella pneumoniae</i>-induced immune response signatures.

Canadian journal of microbiology·2026

Related Experiment Video

Updated: Dec 1, 2025

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

7.3K

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions.

Brianna Ball1, Arjun Sukumaran1, Jennifer Geddes-McAlister2

  • 1Molecular and Cellular Biology Department, University of Guelph.

Journal of Visualized Experiments : Jove
|November 9, 2020
PubMed
Summary

This study introduces a label-free quantification (LFQ) method using mass spectrometry to analyze the proteome of the fungal pathogen Cryptococcus neoformans during host cell infection. The technique reveals key proteins involved in virulence and host response.

More Related Videos

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.6K
A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

997

Related Experiment Videos

Last Updated: Dec 1, 2025

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

7.3K
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.6K
A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

997

Area of Science:

  • Proteomics
  • Infectious Disease Research
  • Microbiology

Background:

  • Mass spectrometry (MS)-based quantitative proteomics enables global proteome analysis under various conditions.
  • Studying host-pathogen interactions is crucial for understanding infection dynamics.
  • Cryptococcus neoformans is a fungal pathogen causing cryptococcosis.

Purpose of the Study:

  • To develop and detail a label-free quantification (LFQ) workflow for analyzing the infectome of Cryptococcus neoformans interacting with host macrophage cells.
  • To provide a comprehensive characterization of both pathogen and host protein perspectives during infection.
  • To optimize protein preparation for simultaneous analysis of microbial and mammalian cells.

Main Methods:

  • Label-free quantification (LFQ) proteomics using liquid-chromatography coupled with tandem mass spectrometry (LC-MS/MS).
  • Standardized protein extraction protocols for both fungal pathogen (C. neoformans) and mammalian host cells (macrophages).
  • High-throughput, sensitive analysis of protein abundance profiles.

Main Results:

  • The LFQ method successfully quantified a wide dynamic range of proteins from both C. neoformans and host cells in a single experiment.
  • The workflow is transferable to various host-pathogen infection models.
  • Identified specific C. neoformans proteins crucial for virulence and host proteins responding to fungal invasion.

Conclusions:

  • The described LFQ workflow provides an unbiased and sensitive method for studying host-pathogen interactions.
  • This approach yields essential insights into microbial pathogenesis and host immune responses.
  • The protocol is adaptable for diverse infection settings, enhancing infectious disease research.